Exploring the Latest Trends in Moderna's Options Market
Financial analysts have observed a notable bullish sentiment surrounding Moderna. Our comprehensive analysis of the options trading history for Moderna (MRNA) has identified 11 unusual trades that deserve further scrutiny.
Our investigation revealed that 45% of traders had a bullish outlook, while 36% demonstrated bearish tendencies. Among the trades we analyzed, there were 3 put options valued at $91,685 and 8 call options valued at $309,766.
Insights on Market Price Targets
By examining trading volumes alongside Open Interest, it becomes clear that the primary price range targeted by major market players for Moderna has been between $70.0 and $105.0 over the last three months.
Analysis of Volume and Open Interest Trends
Currently, the average open interest for Moderna's options stands at 1117.73, with a total trading volume of 1,609.00. This data reflects the fluctuations in call and put option volumes, as well as open interest for significant trades focused on the $70.0 to $105.0 strike price range, observed over the past 30 days.
Overview of Options Volume and Interest Over the Last Month
Key Highlights of Major Options Trades
The recent trading environment for Moderna has featured several noteworthy options transactions:
- Symbol: MRNA | Type: CALL | Trade Type: TRADE | Sentiment: BEARISH | Expiration: 09/13/24 | Price: $6.05 | Total Trade Value: $60.5K | Open Interest: 323 | Volume: 200
- Symbol: MRNA | Type: CALL | Trade Type: SWEEP | Sentiment: BEARISH | Expiration: 09/20/24 | Price: $1.87 | Total Trade Value: $46.2K | Open Interest: 1.3K | Volume: 95
- Symbol: MRNA | Type: CALL | Trade Type: SWEEP | Sentiment: BULLISH | Expiration: 09/27/24 | Price: $1.98 | Total Trade Value: $44.7K | Open Interest: 25 | Volume: 0
- Symbol: MRNA | Type: CALL | Trade Type: SWEEP | Sentiment: BULLISH | Expiration: 10/04/24 | Price: $2.99 | Total Trade Value: $39.7K | Open Interest: 14 | Volume: 210
- Symbol: MRNA | Type: PUT | Trade Type: SWEEP | Sentiment: BULLISH | Expiration: 10/18/24 | Price: $7.45 | Total Trade Value: $36.5K | Open Interest: 4.1K | Volume: 78
Overview of Moderna
Founded in 2010, Moderna is a prominent biotechnology company that went public in December 2018. The company gained rapid recognition for its innovative mRNA technology, particularly with the COVID-19 vaccine, which received authorization in the United States in December 2020. As of mid-2023, Moderna has 39 mRNA development candidates undergoing clinical trials across various therapeutic areas, including infectious diseases, oncology, cardiovascular conditions, and rare genetic disorders.
Given the insights from the recent options trading history, it’s crucial to turn our attention to Moderna's current performance.
Current Market Position of Moderna
- The stock price of MRNA has increased by 6.71%, currently priced at $77.78, with a trading volume of 1,390,951.
- Relative Strength Indicator (RSI) metrics indicate that the stock is in a neutral position, neither overbought nor oversold.
- Investors can expect the next earnings report in about 52 days.
Analyst Forecasts for Moderna
In the past month, analysts have issued ratings for this stock, indicating an average target price of $85.0.
- A JP Morgan analyst has assigned a Neutral rating to Moderna, with a price target of $88.
- Meanwhile, an analyst from HSBC has upgraded their recommendation to Hold, adjusting their target price to $82.
Engaging in options trading carries increased risks, but it also presents opportunities for potential profits. Savvy investors can mitigate risks through ongoing education, strategic adjustments, and close attention to market trends. Stay updated on the latest developments regarding Moderna's option trades.
Frequently Asked Questions
What unusual trades were noted for Moderna?
Our analysis identified 11 unusual trades, with 45% of traders showing a bullish outlook and 36% a bearish one.
What is the price range targeted by traders?
Traders are primarily focusing on a price range between $70.0 and $105.0 for Moderna.
What does the current open interest indicate?
The average open interest is recorded at 1117.73, reflecting strong investor engagement.
How has Moderna performed recently?
Moderna's stock has risen by 6.71%, currently priced at $77.78.
What are the analyst ratings for Moderna?
Recent analyst ratings suggest an average target price of $85.0, with updates from JP Morgan and HSBC providing further insights.